Categories
2023 Press Releases

BOARD OF DIRECTORS APPROVES CONSOLIDATED HALF-YEAR FINANCIAL REPORT AS OF JUNE 30th 2023

Board of directors approves consolidated half-year financial report as of june 30th 2023

Categories
2023 Press Releases

Group Revenues For The Semester Amount To €36.7 Million (+17% YoY) Driven By The Online Retail Channel (+33% YoY)

Group Revenues For The Semester Amount To €36.7 Million (+17% YoY) Driven By The Online Retail Channel (+33% YoY)

Categories
2023 Press Releases

The Board of Directors Identifies the Beneficiaries of the 2022-2024 Stock Grant Plan

The Board of Directors Identifies the Beneficiaries of the 2022-2024 Stock Grant Plan

Categories
2023 Press Releases

Farmacosmo Notification of Change in Share Capital

Farmacosmo Notification of Change in Share Capital

Categories
2023 Press Releases

The Shareholders’ Meeting Approves the 2022 Financial Statement, the Allocation of the Profit for the Year and the Appointment of a Member of the Board of Directors

The Shareholders’ Meeting Approves the 2022 Financial Statement, the Allocation of the Profit for the Year and the Appointment of a Member of the Board of Directors

Categories
2023 Press Releases

Farmacosmo: Supplement To The Notice Of Call Of The Ordinary Shareholders’ Meeting

Farmacosmo: Supplement To The Notice Of Call Of The Ordinary Shareholders’ Meeting

Categories
2023 Press Releases

Farmacosmo: Group Revenues Of €18.8 Million (+6% YoY) Driven By Online Retail Channel (+22% YoY)

Farmacosmo: Group Revenues Of €18.8 Million (+6% YoY) Driven By Online Retail Channel (+22% YoY)

Categories
2023 Press Releases

Notice of Ordinary Shareholders’ Meeting

Notice of Ordinary Shareholders’ Meeting

Categories
2023 Press Releases

Change to the 2023 Corporate Events Calendar

Change to the 2023 Corporate Events Calendar

Categories
2023 Press Releases

Farmacosmo Starts Branding Its First Physical Pharmacies

Farmacosmo Starts Branding Its First Physical Pharmacies